Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.410
+0.030 (1.26%)
Aug 24, 2026, 4:00 PM EDT - Market closed

Protalix BioTherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
18.95-6.62.938.31-14.93-27.58
Depreciation & Amortization
1.571.471.31.191.091.12
Other Amortization
---0.270.32.67
Loss (Gain) From Sale of Assets
---00.01--0.05
Stock-Based Compensation
2.262.33.253.452.092.38
Other Operating Activities
1.530.950.38-4.01-1.531.28
Change in Accounts Receivable
-7.6-5.892.32-0.43-1.19-1.03
Change in Inventory
-11.16-4.49-2.2-2.241.15-4.87
Change in Accounts Payable
6.360.290.75.3-4.82.39
Change in Unearned Revenue
----13.18-7.1613.23
Change in Other Net Operating Assets
-1.98-0.02-00.01-0.010.19
Operating Cash Flow
9.92-11.998.67-1.32-25-10.29
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2.26-1.64-1.28-1.15-0.63-1.46
Sale of Property, Plant & Equipment
--0--0.05
Investment in Securities
2-5.42-15.42-520
Other Investing Activities
-0.77-0.730.08-0.140.590.33
Investing Cash Flow
-1.03-2.374.22-16.71-5.0418.92

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Repaid
------4.09
Long-Term Debt Repaid
---20.42---30.04
Total Debt Repaid
---20.42---34.12
Net Debt Issued (Repaid)
---20.42---34.12
Issuance of Common Stock
0.39.333.6324.678.2446.2
Financing Cash Flow
0.39.33-16.7924.678.2412.08

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.33-0.050.03-0.11-0.080.01
Net Cash Flow
9.53-5.08-3.876.52-21.8720.72

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
7.67-13.637.39-2.47-25.63-11.74
Free Cash Flow Growth
------
Free Cash Flow Margin
9.51%-25.84%13.84%-3.77%-53.80%-30.62%
Free Cash Flow Per Share
0.10-0.170.09-0.03-0.53-0.27
Levered Free Cash Flow
2.99-12.25.43-1.81-7.55-12.86
Unlevered Free Cash Flow
3.76-11.456.1-0.09-6.27-10.83

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--1.532.742.23.41
Cash Income Tax Paid
3.681.180.39---
Change in Working Capital
-14.38-10.10.81-10.54-12.029.9
SEC Filings: 10-K · 10-Q